{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:08:03Z","timestamp":1747166883665,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.lungcan.2016.07.025","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T18:41:42Z","timestamp":1469644902000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor"],"prefix":"10.1016","volume":"100","author":[{"given":"Seung Hwan","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4766-0263","authenticated-orcid":false,"given":"Hae Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Mu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Ju","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2016.07.025_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2016.07.025_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1183\/09059180.00007312","article-title":"Thymic epithelial tumours: from basic principles to individualised treatment strategies","volume":"22","author":"Girard","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11864-009-0083-7","article-title":"Treatment of advanced thymoma and thymic carcinoma","volume":"9","author":"Rajan","year":"2008","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1148\/radiol.14131643","article-title":"Diffusion-weighted MR in thymic epithelial tumors: correlation with World Health Organization classification and clinical staging","volume":"273","author":"Abdel Razek","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.lungcan.2016.07.025_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/RTI.0b013e31828609a0","article-title":"Advances in thymoma imaging","volume":"28","author":"Marom","year":"2013","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.lungcan.2016.07.025_bib0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/JTO.0b013e3182199be2","article-title":"Assessment of objective responses using volumetric evaluation in advanced thymic malignancies and metastatic non-small cell lung cancer","volume":"6","author":"Force","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0040","doi-asserted-by":"crossref","first-page":"S1691","DOI":"10.1097\/JTO.0b013e3182254ac1","article-title":"Standard outcome measures for thymic malignancies","volume":"6","author":"Huang","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0045","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/JTO.0000000000000296","article-title":"A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria","volume":"9","author":"Benveniste","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0050","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","article-title":"Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans","volume":"5","author":"Liu","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00259-014-2960-y","article-title":"Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma","volume":"42","author":"Lopci","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.lungcan.2016.07.025_bib0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12149-010-0455-x","article-title":"18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors","volume":"25","author":"Kaira","year":"2011","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0070","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1158\/1078-0432.CCR-12-2929","article-title":"18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors","volume":"19","author":"Thomas","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0075","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/JTO.0000000000000692","article-title":"A prospective phase II study of cisplatin and cremophor EL-free paclitaxel (Genexol-PM) in patients with unresectable thymic epithelial tumors","volume":"10","author":"Kim","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2016.07.025_bib0080","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtcvs.2009.03.033","article-title":"Comparison of patterns of relapse in thymic carcinoma and thymoma","volume":"138","author":"Huang","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2967\/jnumed.108.054205","article-title":"18F-FDG PET and PET\/CT in the evaluation of cancer treatment response","volume":"50","author":"Ben-Haim","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0095","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.24278","article-title":"18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma","volume":"115","author":"Shibata","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2016.07.025_bib0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12149-009-0283-z","article-title":"Characterization of thymic masses using (18)F-FDG PET-CT","volume":"23","author":"Kumar","year":"2009","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.lungcan.2008.01.003","article-title":"Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors","volume":"61","author":"Endo","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2016.07.025_bib0110","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis","volume":"55","author":"Pak","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3348\/kjr.2013.14.1.1","article-title":"Prognostic significance of volume-based PET parameters in cancer patients","volume":"14","author":"Moon","year":"2013","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0120","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.106.035774","article-title":"Partial-volume effect in PET tumor imaging","volume":"48","author":"Soret","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0125","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ijrobp.2010.10.064","article-title":"Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer","volume":"82","author":"Meng","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2016.07.025_bib0130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.09.039","article-title":"Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning","volume":"67","author":"Hong","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216304238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216304238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T02:24:37Z","timestamp":1536546277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500216304238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":26,"alternative-id":["S0169500216304238"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.025","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}